Welcome to episode 048 of Life Sciences 360.

In this episode, Sharmeen discuss the current one-size-fits-all approach in healthcare and the need for precision dosing. Sharmeen explains how DoseMe platform simplifies complex dosing methods at the bedside, benefiting both clinicians and patients. Sharmeen also touch on the integration with electronic health records and the use of real-world data to improve dosing.

Shownotes :

00:00 Introduction
02:58 User Demographics
04:42 Integration with EHR
10:20 Therapeutic Areas
14:00 Bayesian Method
16:20 Real-time Data
20:20 Nerd Out on the Topic
25:00 AUC-guided Dosing
29:00 Implementation Process

-----
Links:

* Sharmeen Roy LinkedIn (https://www.linkedin.com/in/sharmeenroy/)
* DoseMe LinkedIn (https://www.linkedin.com/company/doseme-pty-ltd/ )
* DoseMe website (https://doseme-rx.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

#PrecisionDosing #BayesianDosing #HealthcareInnovation #DoseMeRx #Pharmacology #ClinicalTrials #IndividualizedMedicine #BayesianMethods #HarshThakkar #SharmeenRoy

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 047 of Life Sciences 360.

In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies stay informed about clinical trials and changes in the industry.

Watch the video to learn how AI can assist in making informed decisions in the life sciences field.

Chapters :
00:00 - Introduction
00:24 - AI in Decision-Making
00:45 - Welcome and Guest Introduction
01:00 - InThought Research and Infernesis
02:00 - Challenges in Clinical Trials
03:40 - InVision Technology Platform
06:36 - AI Integration in InVision
08:22 - Machine Learning and Natural Language Processing
13:20 - Case Study: Clinical Trial Data Analysis
17:56 - Privacy and Regulation in Healthcare
19:34 - AI and Job Security
24:21 -Practical Applications of AI
26:16 - Spire Bioadvisors
29:40 - Trends in Biotech and Drug Development
32:58 - Future of AI in Healthcare
37:28 - Ben's Personal Insights
39:12 - Closing Thoughts

-----
Links:

* Ben Weintraub LinkedIn (https://www.linkedin.com/in/ben-weintraub-0566389/)
* inThought Research LinkedIn (https://www.linkedin.com/company/inthought-research/ )
* inThought Research website (https://inthought.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#AIinHealthcare #ClinicalTrials #DrugDevelopment #LifeSciences360 #BiotechStartups #PersonalizedMedicine #GeneTherapy #MachineLearning #NaturalLanguageProcessing #HealthcareInnovation

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 046 of Life Sciences 360.

On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delve into topics such as manufacturing, strategy formation, and the impact of cell therapy on oncology.

This episode provides valuable information for anyone interested in the field and invites viewers to explore the possibilities of this groundbreaking technology.

Show notes:

00:00 Introduction
02:40 Autologous Cell Therapies
04:40 Formation of CTMC
08:40 Recognition and Impact
11:48 Challenges in Cell Therapy Manufacturing
15:00 Acquisition of a Facility
17:20 Unexpected Growth
21:49 Houston's Support for Multi-Center Trials
27:52 Conceptualizing Virtual Manufacturing
34:20 Maintaining Focus and Vision

-----
Links:
* Jason Bock LinkedIn ( https://www.linkedin.com/in/jason-b-bock/ )
* CTMC LinkedIn
(https://www.linkedin.com/company/celltherapymanufacturingcenter/)
*CTMC website (https://ctmc.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/)

*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

-----

#Biotech #celltherapy #MDAnderson #LifeSciences #CellManufacturing #CancerResearch #AdvancedTherapies #BiotechIndustry #MedicalResearch #InnovativeTherapies #BiotechPartnerships #BiotechCareer #Biopharmaceuticals #DigitalQuality #BiotechLeadership #IndustrialManufacturing #healthcareinnovation #MedicineMakers #Biologics #ClinicalResearch #CancerTreatment

For more, check out the podcast website - www.lifesciencespod.com